-
Study aim
-
Determine the effects of dry needling (DN) on spasticity ,knee and ankle range of motion and function in individuals with chronic stroke
-
Design
-
A randomized, single-blind clinical trial with a parallel group design. The subjects are randomized with permuted block into two groups ( interventional and control)
-
Settings and conduct
-
Subjects are recruited from individuals with chronic stroke who refer to Shiraz School of Rehabilitation Sciences.The study is single-blinded and the assessor of MMAS, knee and ankle ROM and TUG test outcome is unaware of subjects allocation to the groups
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 6 months after a stroke involving cerebral cortical regions. first-ever unilateral stroke.ankle dorsi flexor MMAS spasticity score ≥ 2. able to ambulate without supportive device
exclusion criteria:recurrent stroke. previous treatment with BTXA in the 6 months preceding the study.progressive or severe neurologic diseases, for example, heart conditions, unstable hypertension, fracture, or implants in the lower extremity.fear of needles.any contraindication for deep dry needling
-
Intervention groups
-
interventional group: rehabilitation exercises (strengthening exercise, PNF pattern and gait training), stretch of gastrocnemius, soleus and hip adductors muscles and DN over the gastrocnemius, soleus, tibialis anterior and hip adductors muscles on the spastic leg
control group: rehabilitation exercises (strengthening exercise, PNF pattern and gait training) and stretch of gastrocnemius, soleus and hip adductors muscles
-
Main outcome variables
-
Modified Modified Ashworth Scale (MMAS); range of motion (ROM); Timed up and go (TUG) test